A Study to Evaluate Rituximab in Adults With Relapsing Remitting Multiple Sclerosis

PHASE2CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

December 31, 2006

Conditions
Multiple Sclerosis
Interventions
DRUG

rituximab

Trial Locations (31)

12208

Albany Medical Center, Albany

17822

Geisinger Medical Center, Danville

19104

University Of Pennsylvania Medical Center, Philadelphia

21201

University of Maryland Hospital MS Center, Baltimore

30327

MS Center Of Atlanta, Atlanta

30912

Medical College of Georgia, Augusta

32751

Neurology Associates, P.A., Maitland

32806

Neurological Services Of Orlando, Orlando

32940

Multiple Sclerosis Center of Brevard, Melbourne

32960

MS Center of Vero Beach, Vero Beach

33060

Neurological Associates, Pompano Beach

40202

Kentucky Neuroscience Research, Louisville

43221

The Ohio State University, Columbus

44195

The Cleveland Clinic Foundation, Cleveland

44302

Neurology and Neuroscience Assoc.,INC, Akron

48334

Michigan Institute For Neurological Disorders, Farmington Hills

53215

St. Luke's Medical Center/Center for Neurological Disorders, Milwaukee

58103

Meritcare Neuroscience Clinic, Fargo

59101

Deaconess Billings Clinical Research Division, Billings

66160

University Of Kansas Medical Center, Kansas City

75231

Neurology Specialists of Dallas, PA, Dallas

77030

Maxine Mesinger MS Clinic/ Baylor College of Medicine, Houston

78229

Neurology Clinic of San Antonio, San Antonio

85006

Phoenix Neurological Associates, Phoenix

92354

Loma Linda University, Loma Linda

94596

Neurological Research Institute Of East Bay, Walnut Creek

95355

Sutter Gould Medical Foundation, Modesto

95817

University Of California At Davis, Sacramento

98101

Virginia Mason Medical Center, Seattle

98405

Neurology and Neurosurgery Associates of Tacoma, Inc., P.S., Tacoma

99208

Holy Family MS Center, Spokane

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY